You are here: Industry Insights > opioids

News List

FDA panel slams Alkermes’ opioid-based depression drug fiercebiotech
November 05, 2018
It has been a long and difficult road for Alkermes’ new depression drug, and Thursday’s advisory committee vote won’t make it any easier. The panel voted 21-2 against recommending...
FDA encourages appropriate prescribing of opioids europeanpharmaceuticalreview
September 21, 2018
The FDA has updated its Opioid Analgesic REMS to ensure caregivers and patients use opioids effectively…
FDA to Encourage “Appropriate and Rational” Prescribing of Opioids through New Safety Measures americanpharmaceuticalreview
September 20, 2018
The U.S. Food and Drug Administration (FDA) took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).
FDA committee votes to approve lofexidine for opioid withdrawal pharmaceutical-technology
April 03, 2018
The US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee has voted to approve lofexidine hydrochloride to treat symptoms of opioid withdrawal.
Opioids are no more effective than common painkillers, study reveals pharmafile
March 09, 2018
A research team at the Minneapolis Veterans Affairs health care system found. . .
FDA protects children from opioids by revising labelling in prescription cough and cold products europeanpharmaceuticalreview
January 15, 2018
FDA acts to protect children from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labelling to limit paediatrics use…
Indivior's opioid addiction treatment recommended by FDA advisory panel pharmafile
November 02, 2017
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges that an experimental drug from Indivior which is designed to treat opioid addiction has been recommended by an advisory panel to the FDA
Makers of immediate-release opioids must fund training on their use, FDA says pharmafile
September 30, 2017
As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over 100 citizens a day
FDA evaluates prescription opioid medications approved for children europeanpharmaceuticalreview
August 23, 2017
The FDA has heard from professional groups, including the American Academy of Paediatrics about the use of opioid cough suppressants for children…
Is Infant Drug Withdrawal Likelier When Opioids Used With Psychiatric Drugs? drugs.com
August 03, 2017
More U.S. babies go through drug withdrawal after birth these days, and researchers say doctors' prescribing practices are partly to blame.

Previous page 1 2 3 Next page